Clearside Biomedical(CLSD) - 2023 Q4 - Annual Report
Clearside Biomedical(CLSD)2024-03-12 00:00
(Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FORM 10-K | --- | --- | |---------------------------------------------------------------------------------------|-----------------------------------------------------| | | | | For the | __________ | | Commission | | | (Exact Name of Registrant as Specified in its Charter) | | ...